Cerus (CERS) Competitors $1.25 -0.09 (-6.72%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$1.30 +0.05 (+4.08%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CERS vs. STAA, OSUR, UTMD, ANIK, COO, WST, ALGN, MMSI, ICUI, and HAEShould you be buying Cerus stock or one of its competitors? The main competitors of Cerus include STAAR Surgical (STAA), OraSure Technologies (OSUR), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), Cooper Companies (COO), West Pharmaceutical Services (WST), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), and Haemonetics (HAE). These companies are all part of the "health care supplies" industry. Cerus vs. STAAR Surgical OraSure Technologies Utah Medical Products Anika Therapeutics Cooper Companies West Pharmaceutical Services Align Technology Merit Medical Systems ICU Medical Haemonetics STAAR Surgical (NASDAQ:STAA) and Cerus (NASDAQ:CERS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, community ranking, valuation, analyst recommendations, media sentiment, risk, earnings and profitability. Do insiders & institutionals have more ownership in STAA or CERS? 96.7% of STAAR Surgical shares are held by institutional investors. Comparatively, 78.4% of Cerus shares are held by institutional investors. 1.0% of STAAR Surgical shares are held by company insiders. Comparatively, 3.4% of Cerus shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has stronger valuation & earnings, STAA or CERS? STAAR Surgical has higher revenue and earnings than Cerus. STAAR Surgical is trading at a lower price-to-earnings ratio than Cerus, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSTAAR Surgical$279.13M3.27-$20.21M-$1.44-12.81Cerus$185.14M1.29-$37.49M-$0.10-12.50 Do analysts prefer STAA or CERS? STAAR Surgical presently has a consensus target price of $24.63, suggesting a potential upside of 33.47%. Cerus has a consensus target price of $3.50, suggesting a potential upside of 180.00%. Given Cerus' stronger consensus rating and higher possible upside, analysts plainly believe Cerus is more favorable than STAAR Surgical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score STAAR Surgical 1 Sell rating(s) 9 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Cerus 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk and volatility, STAA or CERS? STAAR Surgical has a beta of 0.65, indicating that its stock price is 35% less volatile than the S&P 500. Comparatively, Cerus has a beta of 1.58, indicating that its stock price is 58% more volatile than the S&P 500. Does the media favor STAA or CERS? In the previous week, STAAR Surgical had 11 more articles in the media than Cerus. MarketBeat recorded 13 mentions for STAAR Surgical and 2 mentions for Cerus. STAAR Surgical's average media sentiment score of 1.20 beat Cerus' score of 0.84 indicating that STAAR Surgical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STAAR Surgical 9 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cerus 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is STAA or CERS more profitable? STAAR Surgical has a net margin of -6.44% compared to Cerus' net margin of -11.60%. STAAR Surgical's return on equity of -3.35% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets STAAR Surgical-6.44% -3.35% -2.67% Cerus -11.60%-40.55%-11.12% Does the MarketBeat Community prefer STAA or CERS? Cerus received 281 more outperform votes than STAAR Surgical when rated by MarketBeat users. Likewise, 72.34% of users gave Cerus an outperform vote while only 53.92% of users gave STAAR Surgical an outperform vote. CompanyUnderperformOutperformSTAAR SurgicalOutperform Votes28953.92% Underperform Votes24746.08% CerusOutperform Votes57072.34% Underperform Votes21827.66% SummarySTAAR Surgical and Cerus tied by winning 9 of the 18 factors compared between the two stocks. Get Cerus News Delivered to You Automatically Sign up to receive the latest news and ratings for CERS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CERS vs. The Competition Export to ExcelMetricCerusSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$238.95M$4.47B$5.35B$8.38BDividend YieldN/A43.64%5.22%4.10%P/E Ratio-11.3629.4326.8419.71Price / Sales1.2967.72391.39116.98Price / CashN/A51.0838.2534.62Price / Book4.316.236.794.50Net Income-$37.49M$68.16M$3.23B$248.18M7 Day PerformanceN/A18.33%4.07%1.14%1 Month Performance-3.10%23.04%12.52%15.20%1 Year Performance-32.43%20.61%16.83%6.56% Cerus Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CERSCerus2.8923 of 5 stars$1.25-6.7%$3.50+180.0%-32.4%$238.95M$185.14M-11.36290Positive NewsGap UpSTAASTAAR Surgical4.0742 of 5 stars$20.27+4.4%$24.63+21.5%-56.6%$1.00B$279.13M-49.44960Analyst ForecastBuyback AnnouncementGap UpOSUROraSure Technologies4.0312 of 5 stars$2.67+6.4%$5.50+106.0%-48.0%$206.89M$185.83M17.80840Analyst ForecastUTMDUtah Medical Products2.1592 of 5 stars$54.02+0.8%N/A-22.4%$177.29M$39.27M13.68180Dividend AnnouncementANIKAnika Therapeutics4.1355 of 5 stars$11.85+1.8%$21.33+80.0%-54.5%$169.94M$119.91M-1.78300Gap UpCOOCooper Companies3.1303 of 5 stars$84.44+2.6%$110.25+30.6%-18.0%$16.89B$3.93B43.3014,000Positive NewsUpcoming EarningsAnalyst UpgradeWSTWest Pharmaceutical Services4.5681 of 5 stars$219.20+2.9%$332.50+51.7%-38.0%$15.75B$2.90B32.7710,700Trending NewsAnalyst RevisionALGNAlign Technology4.781 of 5 stars$189.00+3.9%$241.25+27.6%-34.9%$13.84B$3.98B33.6923,200Positive NewsMMSIMerit Medical Systems4.1455 of 5 stars$98.73+3.0%$107.78+9.2%+17.2%$5.83B$1.39B48.406,850Trending NewsAnalyst ForecastInsider TradeAnalyst RevisionICUIICU Medical4.7589 of 5 stars$144.34+4.4%$192.67+33.5%+27.3%$3.55B$2.38B-31.5814,500Insider TradeGap UpHAEHaemonetics4.3169 of 5 stars$70.23+3.0%$97.89+39.4%-28.2%$3.53B$1.36B27.652,820Analyst ForecastGap Up Related Companies and Tools Related Companies STAA Competitors OSUR Competitors UTMD Competitors ANIK Competitors COO Competitors WST Competitors ALGN Competitors MMSI Competitors ICUI Competitors HAE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CERS) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cerus Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cerus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.